Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.
Silverberg JI, Rosmarin D, Chovatiya R, Bieber T, Schleicher S, Beck L, Gooderham M, Chaudhry S, Fanton C, Yu D, Levy J, Liu Y, Miyazaki T, Tagliaferri M, Schmitz C, Nirula A, Kotzin B, Zalevsky J. Silverberg JI, et al. Among authors: schleicher s. Nat Commun. 2024 Oct 25;15(1):9230. doi: 10.1038/s41467-024-53384-1. Nat Commun. 2024. PMID: 39455575 Free PMC article. Clinical Trial.
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Griffiths CE, Reich K, Lebwohl M, van de Kerkhof P, Paul C, Menter A, Cameron GS, Erickson J, Zhang L, Secrest RJ, Ball S, Braun DK, Osuntokun OO, Heffernan MP, Nickoloff BJ, Papp K; UNCOVER-2 and UNCOVER-3 investigators. Griffiths CE, et al. Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10. Lancet. 2015. PMID: 26072109 Clinical Trial.
Association of Participation in Medicare's Oncology Care Model With Spending, Utilization, and Quality Outcomes Among Commercially Insured and Medicare Advantage Members.
Mullangi S, Ukert B, Devries A, Debono D, Santos J, Fisch MJ, Schleicher SM, Navathe AS, Bekelman JE, Schwartz AL, Parikh RB. Mullangi S, et al. Among authors: schleicher sm. J Clin Oncol. 2024 Oct 2:JCO2400502. doi: 10.1200/JCO.24.00502. Online ahead of print. J Clin Oncol. 2024. PMID: 39356984
Practice Consolidation Among US Medical Oncologists, 2015-2022.
Milligan M, Erfani P, Orav EJ, Schleicher S, Brooks GA, Lam MB. Milligan M, et al. Among authors: schleicher s. JCO Oncol Pract. 2024 Jun;20(6):827-834. doi: 10.1200/OP.23.00748. Epub 2024 Feb 26. JCO Oncol Pract. 2024. PMID: 38408291
Comparison of induction agents for rapid sequence intubation in refractory status epilepticus: A single-center retrospective analysis.
Woodward MR, Kardon A, Manners J, Schleicher S, Pergakis MB, Ciryam P, Podell J, Denney Zimmerman W, Galvagno SM Jr, Butt B, Pritchard J, Parikh GY, Gilmore EJ, Badjatia N, Morris NA. Woodward MR, et al. Among authors: schleicher s. Epilepsy Behav Rep. 2024 Jan 8;25:100645. doi: 10.1016/j.ebr.2024.100645. eCollection 2024. Epilepsy Behav Rep. 2024. PMID: 38299124 Free PMC article.
138 results